Γ
SynBioBeta 2026. May 4-7, San Jose Convention Centre, California

Meet the AI × Bio companies shaping the next wave of pharma, evaluate their platforms, and start the conversations that turn into partnerships.

If you’re at a pharma company, you can apply for a complimentary one-day pass.

AI-native drug discovery. $1B backed by ARCH and Foresite.

AI-native drug discovery. $1B backed by ARCH and Foresite.

AI cancer therapeutics. Spatial biology and virtual cell models.

AI cancer therapeutics. Spatial biology and virtual cell models.

GPT-Rosalind life sciences model. AI built for drug discovery and biology.

GPT-Rosalind life sciences model. AI built for drug discovery and biology.

Claude for Life Sciences. Frontier AI for drug discovery and biology research.

Claude for Life Sciences. Frontier AI for drug discovery and biology research.

Silicon photonics for protein sequencing. Stanford spinout, DARPA-backed.

Silicon photonics for protein sequencing. Stanford spinout, DARPA-backed.

AI-powered RNA drug discovery. Targeting the undruggable.

AI-powered RNA drug discovery. Targeting the undruggable.

AlphaFold team alumni. De novo antibody design.

AlphaFold team alumni. De novo antibody design.

Virtual cell-signaling models. Designing regenerative therapies.

Virtual cell-signaling models. Designing regenerative therapies.

Clinical-stage TechBio. World's largest biological dataset.

Clinical-stage TechBio. World's largest biological dataset.

100M single-cell dataset. Powering virtual cell models.

100M single-cell dataset. Powering virtual cell models.

100M single-cell dataset. Powering virtual cell models.

100M single-cell dataset. Powering virtual cell models.

Computational drug design at pharma scale. Diabetes, obesity, and rare disease therapies.

Computational drug design at pharma scale. Diabetes, obesity, and rare disease therapies.

100M single-cell dataset. Powering virtual cell models.

100M single-cell dataset. Powering virtual cell models.

AI protein design platform. Therapeutics to agriculture.

AI protein design platform. Therapeutics to agriculture.

Open-source biomolecular AI. Structure prediction and drug design.

Open-source biomolecular AI. Structure prediction and drug design.

De novo miniprotein design. Immune and allergy targets.

De novo miniprotein design. Immune and allergy targets.

AI-designed AAV capsids for gene therapy. Partnered with Novartis.

AI-designed AAV capsids for gene therapy. Partnered with Novartis.

Biomolecular structure prediction. Open-source Chai-1 model.

Biomolecular structure prediction. Open-source Chai-1 model.

AI drug discovery. Small molecules and biologics.

AI drug discovery. Small molecules and biologics.

AI co-scientist for life science R&D teams.

AI co-scientist for life science R&D teams.

Generative protein design. Partnered with AstraZeneca and Takeda.

Generative protein design. Partnered with AstraZeneca and Takeda.

Hyperscaled protein library design and functional screening.

Hyperscaled protein library design and functional screening.

ML-driven antibody design. Partnered with Lilly and J&J.

ML-driven antibody design. Partnered with Lilly and J&J.

Multiplexed in vivo protein testing. Barcoded biologics.

Multiplexed in vivo protein testing. Barcoded biologics.

AI lab for scientific world models. Biology and drug discovery.

AI lab for scientific world models. Biology and drug discovery.

Creators of AlphaFold. AI for scientific discovery.

Creators of AlphaFold. AI for scientific discovery.

Silicon-chip DNA synthesis. Powering drug discovery and synthetic biology.

Silicon-chip DNA synthesis. Powering drug discovery and synthetic biology.

BioNeMo platform. AI infrastructure powering drug discovery at scale.

BioNeMo platform. AI infrastructure powering drug discovery at scale.

Physics + ML for small-molecule drug discovery. Rooted in OpenMM.

Physics + ML for small-molecule drug discovery. Rooted in OpenMM.

iPSC-derived human tissue platform. Scalable data for a biological simulator.

iPSC-derived human tissue platform. Scalable data for a biological simulator.

Cellular rejuvenation and health. Computational biology at unprecedented scale.

Cellular rejuvenation and health. Computational biology at unprecedented scale.

AI-first protein design. Creators of OpenCRISPR, fully AI-designed gene editors.

AI-first protein design. Creators of OpenCRISPR, fully AI-designed gene editors.

Enzymatic DNA synthesis. The complex sequences others can't make.

Enzymatic DNA synthesis. The complex sequences others can't make.

Computational protein design. Designer enzymes at commercial scale.

Computational protein design. Designer enzymes at commercial scale.

Egg-based bioreactors for biologics manufacturing.

Egg-based bioreactors for biologics manufacturing.

Fruit-fly biomanufacturing for hard-to-express proteins.

Fruit-fly biomanufacturing for hard-to-express proteins.

AI bioprocess data platform for biomanufacturing.

AI bioprocess data platform for biomanufacturing.

Complementary 1 Day Pass

Free

If you’re at a pharma company, you can apply for a complimentary one-day pass.

Access to All Sessions

Attendee Directory

Networking Reception

1:1 Partnering App

1:1 Meeting Space

Lunch & Refreshments

Post Event Video Access